Hang Li

Zunyi, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Prognostic factors and overall survival for second primary malignancies in myelodysplastic syndromes: a Cox regression coupled with competing risk model based on Surveillance, Epidemiology, and End Results (SEER) database.

Prognostic factors and overall survival for second primary malignancies in myelodysplastic syndromes: a Cox regression coupled with competing risk model based on Surveillance, Epidemiology, and End Results (SEER) database.

Journal: Translational cancer research
Published: April 15, 2025

Mechanism of USP11 regulated SIRT3/ROS in drug resistance of acute myeloid leukemia.

Mechanism of USP11 regulated SIRT3/ROS in drug resistance of acute myeloid leukemia.

Journal: Clinical and experimental medicine
Published: April 02, 2025

Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis.

Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis.

Journal: Human vaccines & immunotherapeutics
Published: January 17, 2025

Gene regulatory mechanisms of T cell exhaustion in diffuse large B cell lymphoma based on single-cell transcriptome data.

Gene regulatory mechanisms of T cell exhaustion in diffuse large B cell lymphoma based on single-cell transcriptome data.

Journal: Leukemia research
Published: May 24, 2024

Artesunate reverses cytarabine resistance in acute myeloid leukemia by blocking the JAK/STAT3 signaling.

Artesunate reverses cytarabine resistance in acute myeloid leukemia by blocking the JAK/STAT3 signaling.

Journal: Hematology (Amsterdam, Netherlands)
Published: October 10, 2023

Retraction notice to "Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo" [Biochmie 142C (2017) 144-151].

Retraction notice to "Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo" [Biochmie 142C (2017) 144-151].

Journal: Biochimie
Published: January 09, 2023

Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development.

Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development.

Journal: Frontiers in oncology
Published: March 08, 2019

RETRACTED: Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo.

RETRACTED: Globularifolin exerts anticancer effects on glioma U87 cells through inhibition of Akt/mTOR and MEK/ERK signaling pathways in vitro and inhibits tumor growth in vivo.

Journal: Biochimie
Published: July 18, 2017

Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma.

Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma.

Journal: Anti-cancer drugs
Published: January 16, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026